These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10544850)

  • 21. Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.
    Hinze CH; Speth F; Oommen PT; Haas JP
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):38. PubMed ID: 29925381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis.
    Hoff LS; de Souza FHC; Miossi R; Shinjo SK
    Rheumatology (Oxford); 2022 Apr; 61(4):1579-1588. PubMed ID: 34302454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polymyositis and dermatomyositis in childhood].
    Rodríguez Núñez A; Fernández Bustillo JM; Rodríguez Pérez E; Novo Rodríguez I; Pérez Becerra E; Peña Guitián J; Castro Gago M
    An Esp Pediatr; 1988 Oct; 29(4):288-92. PubMed ID: 3069018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.
    Seshadri R; Feldman BM; Ilowite N; Cawkwell G; Pachman LM
    Arthritis Rheum; 2008 Jul; 59(7):989-95. PubMed ID: 18576304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Juvenile dermatomyositis].
    Dressler F; Huppertz HI
    Z Rheumatol; 2006 Nov; 65(7):587-90, 592-4. PubMed ID: 17051362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis.
    Wang A; Morgan GA; Paller AS; Pachman LM
    J Am Acad Dermatol; 2021 Jun; 84(6):1610-1618. PubMed ID: 33359787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease patterns of juvenile dermatomyositis from Western India.
    Chickermane PR; Mankad D; Khubchandani RP
    Indian Pediatr; 2013 Oct; 50(10):961-3. PubMed ID: 23798628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients.
    Johnson NE; Arnold WD; Hebert D; Gwathmey K; Dimachkie MM; Barohn RJ; McVey AL; Pasnoor M; Amato AA; McDermott MP; Kissel J; Heatwole CR
    Neuromuscul Disord; 2015 Aug; 25(8):625-31. PubMed ID: 26022999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of chronic inflammatory demyelinating polyneuropathy with high dose intravenous methylprednisolone monthly for five years: 10-Year follow up.
    Börü ÜT; Erdoğan H; Alp R; Taşdemir M; Yıldırım S; Bilgiç A; Duman A; Arslan A
    Clin Neurol Neurosurg; 2014 Mar; 118():89-93. PubMed ID: 24529237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of pulse corticosteroid therapy for juvenile dermatomyositis.
    Paller AS
    Pediatr Dermatol; 1996; 13(4):347-8. PubMed ID: 8844758
    [No Abstract]   [Full Text] [Related]  

  • 31. [Methylprednisolone pulse therapy in Kawasaki disease].
    Miura M; Matsuoka M; Kohno K; Ohki H; Yoshiba S
    Nihon Rinsho; 2008 Feb; 66(2):338-42. PubMed ID: 18265457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
    Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
    J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.
    Perumal JS; Caon C; Hreha S; Zabad R; Tselis A; Lisak R; Khan O
    Eur J Neurol; 2008 Jul; 15(7):677-80. PubMed ID: 18459972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.
    Kim S; El-Hallak M; Dedeoglu F; Zurakowski D; Fuhlbrigge RC; Sundel RP
    Arthritis Rheum; 2009 Jun; 60(6):1825-1830. PubMed ID: 19479872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.
    Riley P; McCann LJ; Maillard SM; Woo P; Murray KJ; Pilkington CA
    Rheumatology (Oxford); 2008 Jun; 47(6):877-80. PubMed ID: 18403404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lung is involved in juvenile dermatomyositis.
    Pouessel G; Deschildre A; Le Bourgeois M; Cuisset JM; Catteau B; Karila C; Nève V; Thumerelle C; Quartier P; Tillie-Leblond I
    Pediatr Pulmonol; 2013 Oct; 48(10):1016-25. PubMed ID: 23281200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?
    Wargula JC; Lovell DJ; Passo MH; Bove KE; Santangelo JD; Levinson JE
    Clin Exp Rheumatol; 2006; 24(3):333-43. PubMed ID: 16870106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features.
    Stringer E; Singh-Grewal D; Feldman BM
    Arthritis Rheum; 2008 Nov; 58(11):3585-92. PubMed ID: 18975314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid refractory interstitial pneumonitis in a patient with juvenile dermatomyositis.
    Lin YC; Yang YH; Lin YT; Chiang BL
    J Microbiol Immunol Infect; 2002 Dec; 35(4):259-61. PubMed ID: 12542253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis.
    Malek A; Raeeskarami SR; Ziaee V; Aghighi Y; Moradinejad MH
    Clin Rheumatol; 2014 Aug; 33(8):1113-8. PubMed ID: 24878926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.